Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 134
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Psilocybin for OCD: Terence Ching on Lessons from Yale’s Randomised Trials
Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin, DMT, and Methylone Studies; RAND Polling Reveals 23% of Americans Support Legal Psilocybin...
Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin, DMT, and Methylone Studies; RAND Polling Reveals 23% of Americans Support Legal Psilocybin...
Seeing Through the Veil: Why Psychedelic Experiences Often Feel More Real Than Ordinary Life
Seeing Through the Veil: Why Psychedelic Experiences Often Feel More Real Than Ordinary Life
Abuse Potential: Considerations for Rescheduling MDMA and Psychedelics
PT376 – Ketamine and Psychedelic-Assisted Therapy as Employee Benefits
Psychedelic Bulletin #125: New Data Boosts Spravato’s Case; Bipartisan Breakthrough Therapies...
Psychedelic Research Bulletin: November 2022
Psychedelics Weekly – Cannabis as an Adjunct Cancer Treatment & 5-MeO-DMT...
Numinus Wellness Inc. Reports Q4 2022 and Annual Results
PsyBio Therapeutics Announces Non-Brokered Private Placement Financing
FILAMENT HEALTH ANNOUNCES NEW UNITED STATES PATENT ISSUANCES
Revive Therapeutics Ltd. Announces Offering of Up to $5 Million
Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming...
Load more
